12:00 AM
Jan 14, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Brain cancer CCAAT enhancer binding protein-b (CEBPB; CRP2); signal transducer and activator of transcription 3 (STAT3) A...

Read the full 217 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >